Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 8;11(4):568.
doi: 10.3390/biology11040568.

Self or Non-Self? It Is also a Matter of RNA Recognition and Editing by ADAR1

Affiliations
Review

Self or Non-Self? It Is also a Matter of RNA Recognition and Editing by ADAR1

Valentina Tassinari et al. Biology (Basel). .

Abstract

A-to-I editing is a post-transcriptional mechanism affecting coding and non-coding dsRNAs, catalyzed by the adenosine deaminases acting on the RNA (ADAR) family of enzymes. A-to-I modifications of endogenous dsRNA (mainly derived from Alu repetitive elements) prevent their recognition by cellular dsRNA sensors, thus avoiding the induction of antiviral signaling and uncontrolled IFN-I production. This process, mediated by ADAR1 activity, ensures the activation of an innate immune response against foreign (non-self) but not self nucleic acids. As a consequence, ADAR1 mutations or its de-regulated activity promote the development of autoimmune diseases and strongly impact cell growth, also leading to cancer. Moreover, the excessive inflammation promoted by Adar1 ablation also impacts T and B cell maturation, as well as the development of dendritic cell subsets, revealing a new role of ADAR1 in the homeostasis of the immune system.

Keywords: ADAR1; IFN; RNA editing; immune system.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Effect of ADAR1-mediated A-to-I editing on endogenous and exogenous dsRNA. In the presence of ADAR1, endogenous dsRNA is edited (red square) and does not activate MDA5, RIG-I and PKR (homeostasis, normal tissues). In case of ADAR1 deficiency or mutation, endogenous dsRNA is not edited and recognized as non-self, as for exogenous microbial RNA, leading to IFN (IFN-I and -III) production, a strong ISG signature and uncontrolled immune response activation (chronic inflammation, autoimmune diseases). On the contrary, when ADAR1 is overexpressed, IFNs and their ISGs are dampened, limiting immune responses (tumor).

References

    1. Zinkernagel R.M. On ‘reactivity’ versus ‘tolerance’. Immunol. Cell Biol. 2004;82:343–352. doi: 10.1111/j.0818-9641.2004.01255.x. - DOI - PubMed
    1. Barak M., Porath H.T., Finkelstein G., Knisbacher B.A., Buchumenski I., Roth S.H., Levanon E.Y., Eisenberg E. Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity. Genome Biol. 2020;21:26. doi: 10.1186/s13059-020-1937-3. - DOI - PMC - PubMed
    1. Mannion N.M., Greenwood S.M., Young R., Cox S., Brindle J., Read D., Nellaker C., Vesely C., Ponting C.P., McLaughlin P.J., et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 2014;9:1482–1494. doi: 10.1016/j.celrep.2014.10.041. - DOI - PMC - PubMed
    1. Crow Y.J., Chase D.S., Lowenstein Schmidt J., Szynkiewicz M., Forte G.M., Gornall H.L., Oojageer A., Anderson B., Pizzino A., Helman G., et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am. J. Med. Genet. A. 2015;167:296–312. doi: 10.1002/ajmg.a.36887. - DOI - PMC - PubMed
    1. Crow Y.J., Manel N. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat. Rev. Immunol. 2015;15:429–440. doi: 10.1038/nri3850. - DOI - PubMed